Tablet Bottles vs. Blisters: OEM/ODM Finished-Pack Comparison

Define how the consumer will access tablets

Begin the packaging discussion with the tablet count, intended serving arrangement, and expected access pattern. A bottle groups tablets in one container; a blister organizes them in individual cavities. Compare the actual proposed presentations rather than selecting a format only because it looks familiar on a competitor’s product or an empty packaging sample.

List the commercial requirements alongside the technical questions. These may include retail display, shipping case dimensions, opening experience, and the area needed for directions and declarations. Identify which requirements are essential and which are preferences. The supplier can then propose options that can be assessed against one consistent brief.

Ask about the complete component system

For a bottle proposal, identify the container, closure, liner, seal, and any protective component. For a blister, identify the proposed forming and lidding materials and finished cavity configuration. Record supplier grades or component specifications where relevant. A description such as protective packaging is too broad to establish what the quotation and trial actually include.

An experimental packaging study of hygroscopic medication tablets and a pharmaceutical blister modeling study evaluated product and package relationships in specific systems. Their outcomes are not supplement shelf-life guarantees. They provide context for requesting evidence with the actual tablet and components instead of assuming performance from the format name alone.

Review filled samples and practical handling

Inspect samples filled to the intended count. For bottles, review dispensing and remaining space; for blisters, review access and the intended user action. Ask the qualified team to plan relevant opening and handling assessments. Record observations consistently so the decision is based on the proposed commercial presentation rather than one carefully arranged photographic sample.

Include the agreed transport configuration when evaluating chipping, abrasion, or package damage. Keep the shipping case and retail unit identified in the report. If a change is proposed after the trial, ask whether the earlier observations still apply. The package system should be approved as a specific configuration with any remaining questions clearly stated.

Compare costs with equivalent scope

Ask for quotations using the same tablet revision, quantity, testing plan, and delivery basis. Identify packaging component costs, artwork or setup work, and any development items separately where practical. A lower unit price may describe a different count or an incomplete scope, so normalize the proposals before drawing a commercial conclusion.

Review the schedule implications of tooling, components, artwork, and finished-pack testing. Have the supplier identify what is available and what depends on a later approval. Keep the proposed pack dimensions and printing area aligned with the label draft. This avoids choosing a format whose commercial assumptions no longer match the product brief.

Make finished-pack evidence part of approval

Link the chosen pack to the actual formula, tablet geometry, finishing, component specifications, and study records. Ask what evidence supports the proposed shelf life and any handling instructions. A finished pack can be promising while still awaiting part of the development review; distinguish that status from an approved commercial release decision.

For a repeat order or packaging redesign, review substitutions through the same system. A new closure, lidding material, pack count, or tablet shape may change the earlier configuration. Record the qualified team’s assessment and any required additional work before accepting it. This makes packaging decisions usable beyond the first visual approval.

Common questions